Report: 20 percent of nursing home residents receive antipsychotics
By
Kristen Fischer
Mar 20, 2024
A new report highlights the high number of nursing home residents who are prescribed antipsychotic drugs. Authors of the report say that, in most cases, the drugs aren’t clinically justified.
Disadvantages, understaffing combine to ratchet up nursing homes’ antipsychotic reliance: study
By
Josh Henreckson
Apr 25, 2024
Nursing homes in disadvantaged neighborhoods are more likely to rely on antipsychotics, especially when understaffed, compared to those in more affluent areas, according to a new study in Jama Network...
Study: Medicare warnings cut antipsychotics in nursing home residents, others
By
Kristen Fischer
Apr 26, 2024
When Medicare sent warning letters urging doctors to lower antipsychotic prescriptions, it worked, a report published Thursday in JAMA Network Open found.
Antipsychotic prescribing higher at nursing homes in disadvantaged areas: study
By
Kristen Fischer
Apr 25, 2024
Nursing homes in disadvantaged communities are more likely to overmedicate residents with antipsychotics, according to a study published Wednesday in JAMA Network Open.
With ‘hundreds’ of facilities audited over schizophrenia, CMS pursues harsher antipsychotics stance
By
Kimberly Marselas
Jan 19, 2024
With half of nursing homes audited in a new process admitting to misdiagnosing schizophrenia patients, the Centers for Medicare & Medicaid Services is extending its drive to reduce the use of certain drugs...